Blog

Lucia Masarova: Let’s tackle the inflammation in myelofibrosis! Era of combinational therapies is here

Photo of Lucia Masarova taken from LinkedIn

Nov 22, 2023, 02:47

Lucia Masarova: Let’s tackle the inflammation in myelofibrosis! Era of combinational therapies is here

Lucia Masarova, Assistant Professor of the Department of Leukemia at MD Anderson Cancer Center, shared a post by Simrit Parmar, Assistant Professor of Stem Cell Transplant and Cellular Therapy at MD Anderson Cancer Centre on LinkedIn:

“Exciting, innovative, promising! Let’s tackle the inflammation in myelofibrosis! The era of combinational therapies is here.”

Quoting Simrit Parmar’s post:

“CXCR4 enriched T-Regulatory Cells Preferentially Home to Bone Marrow and Decrease Inflammation
oral presentation by Meixian Huang at 65th Annual American Society of Hematology meeting on Saturday, December 9, 2023 at 4:30 PM.”

For details click here.
Source: Lucia Masarova/LinkedIn and Simrit Parmar/LinkedIn

American Society of Hematology cancer Cellular Therapy CXCR4 Leukemia Lucia Masarova MD Anderson Cancer Center Meixian Huang myelofibrosis OncoDaily Oncology Simrit Parmar Stem Cell Transplant

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 9

Shannon Miller and Ovarian Cancer: How She Went Against, How She Survived, and More

ASTRO Overview: Everything You Need to Know About the Leading Radiation Oncology Society

Kamala Harris vs Donald Trump on Cancer: From Cancer Moonshot to Right to Act, Funding, Research and Future

Dr. Richard Pazdur: 25 Years of Transforming Oncology Drug Development at the FDA

Special Coverage